IRIS
BIANCONE, LIVIA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 48.334
EU - Europa 4.691
AS - Asia 1.928
SA - Sud America 53
Continente sconosciuto - Info sul continente non disponibili 17
OC - Oceania 10
AF - Africa 8
Totale 55.041
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 48.303
IT - Italia 1.248
SG - Singapore 1.049
UA - Ucraina 699
DE - Germania 688
CN - Cina 614
IE - Irlanda 564
FR - Francia 308
RU - Federazione Russa 290
SE - Svezia 272
GB - Regno Unito 188
FI - Finlandia 176
KR - Corea 140
PL - Polonia 87
BE - Belgio 54
BR - Brasile 35
CZ - Repubblica Ceca 28
JP - Giappone 24
NL - Olanda 24
CA - Canada 22
ID - Indonesia 15
IN - India 15
ES - Italia 13
EU - Europa 13
VN - Vietnam 13
DK - Danimarca 11
GR - Grecia 10
HK - Hong Kong 10
KG - Kirghizistan 9
AU - Australia 8
PE - Perù 7
RO - Romania 7
IR - Iran 6
CH - Svizzera 5
AT - Austria 4
IL - Israele 4
MX - Messico 4
PH - Filippine 4
TH - Thailandia 4
AL - Albania 3
CL - Cile 3
DM - Dominica 3
EC - Ecuador 3
EG - Egitto 3
HR - Croazia 3
PK - Pakistan 3
PT - Portogallo 3
UZ - Uzbekistan 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
AR - Argentina 2
KH - Cambogia 2
NZ - Nuova Zelanda 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
TR - Turchia 2
VE - Venezuela 2
ZA - Sudafrica 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
BD - Bangladesh 1
BG - Bulgaria 1
BJ - Benin 1
BT - Bhutan 1
CO - Colombia 1
CR - Costa Rica 1
CY - Cipro 1
GE - Georgia 1
KW - Kuwait 1
KZ - Kazakistan 1
LT - Lituania 1
LV - Lettonia 1
MD - Moldavia 1
PA - Panama 1
PS - Palestinian Territory 1
SA - Arabia Saudita 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 55.041
Salva come PNG Salva come JPEG
Città #
Woodbridge 14.569
Wilmington 12.608
Houston 11.756
Fairfield 1.556
Ann Arbor 1.272
Singapore 903
Chandler 757
Ashburn 698
Seattle 688
Jacksonville 601
Cambridge 517
Dublin 493
Rome 426
Medford 376
Dearborn 332
Santa Clara 224
Beijing 209
Lawrence 178
New York 145
Zhengzhou 118
San Diego 100
Kraków 83
Menlo Park 74
Milan 68
Mülheim 61
Moscow 59
Brussels 53
Redwood City 46
Helsinki 41
Shanghai 37
Boardman 32
Palo Alto 30
Norwalk 28
Verona 28
University Park 27
Mountain View 24
Florence 23
Munich 22
Nanjing 22
Council Bluffs 21
London 21
Hefei 19
Kunming 19
Brno 17
Palermo 16
Naples 15
San Mateo 15
Jakarta 14
Seoul 14
Los Angeles 13
Nürnberg 13
Bologna 12
Hangzhou 12
Toronto 12
Catania 11
Chicago 11
Jinan 11
San Francisco 11
Falls Church 10
Nanchang 10
Saint Petersburg 10
Cedarhurst 9
Detroit 9
Guangzhou 9
Kilburn 9
Colorado Springs 8
Hanover 8
Olomouc 8
Changsha 7
Chongqing 7
Dong Ket 7
Lima 7
Napoli 7
Phoenix 7
Portland 7
Amsterdam 6
Del Norte 6
Frankfurt am Main 6
Lappeenranta 6
Latina 6
Manitou Springs 6
Modena 6
Montecorvino Rovella 6
Serra 6
São Paulo 6
Auburn Hills 5
Cagliari 5
Copenhagen 5
Fuzhou 5
Hanoi 5
Hounslow 5
Nuremberg 5
San Giuliano Milanese 5
Turin 5
Wuhan 5
Anzio 4
Bari 4
Biancavilla 4
Brisbane 4
Caserta 4
Totale 49.830
Salva come PNG Salva come JPEG
Nome #
Le malattie infiammatorie croniche intestinali. In: Manuale di Gastroenterologia. UNIGASTRO. Coordinamento Nazionale Docenti Universitari di Gastroenterologia. 775
A functional role of flip in conferring resistance of Crohn's disease lamina propria lymphocytes to FAS-mediated apoptosis 481
Adenoma, advanced adenoma and colorectal cancer prevalence in asymptomatic 40- to 49-year-old subjects with a first-degree family history of colorectal cancer 469
ATG16L1 Ala197Thr Is Not Associated With Susceptibility to Crohn's Disease or With Phenotype in an Italian Population 466
Local injection of infliximab in the postoperative recurrence of Crohn's disease 463
Defective expression of SIRT1 contributes to sustain inflammatory pathways in the gut 454
Technetium-99m-HMPAO labeled leukocyte single photon emission computerized tomography (SPECT) for assessing Crohn's disease extent and intestinal infiltration 447
Aryl hydrocarbon receptor-induced signals up-regulate IL-22 production and inhibit inflammation in the gastrointestinal tract 447
Cancer and immunomodulators in inflammatory bowel diseases 445
Ileal lesions in patients with ulcerative colitis after ileo-rectal anastomosis: relationship with colonic metaplasia 443
Unsedated transnasal versus transoral sedated upper gastrointestinal endoscopy: a one-series prospective study on safety and patient acceptability 440
Bowel ultrasonography as an aid for diagnosis of intestinal acute graft-versus-host-disease after allogeneic haematopoietic stem cell transplantation 438
3020insC mutation within the NOD2 gene in Crohn's disease: frequency and association with clinical pattern in an Italian population 435
Transcriptional and post-translational regulation of Flip, an inhibitor of Fas-mediated apoptosis, in human gut inflammation 434
Psoriasis Phenotype in Inflammatory Bowel Disease: A Case-Control Prospective Study 434
Infliximab and newly diagnosed neoplasia in Crohn's disease: A multicentre matched pair study 433
Impact of a multidisciplinary approach in enteropathic spondyloarthritis patients 432
Beclomethasone dipropionate versus mesalazine in distal ulcerative colitis: a multicenter, randomized, double-blind study 428
A family study of asymptomatic small bowel Crohn's disease 426
Adalimumab in active ulcerative colitis: A “real-life” observational study 423
Patologie dello stomaco. Gastrite, ulcera, resezione gastrica, dumping sindrome. In: Manuale di nutrizione clinica e scienze dietetiche applicate. 423
123I-interleukin-2 scintigraphy for in vivo assessment of intestinal mononuclear cell infiltration in Crohn's disease 422
Distinct profiles of effector cytokines mark the different phases of Crohn's disease 421
Le malattie infiammatorie croniche intestinali. 420
Fistulizing pattern in Crohn's disease and pancolitis in ulcerative colitis are independent risk factors for cancer: a single-center cohort study 419
Autophagy and inflammatory bowel disease: Association between variants of the autophagy-related IRGM gene and susceptibility to Crohn's disease 417
Frequency and pattern of endoscopic recurrence in Crohn's disease patients with ileocolonic resection using a laparoscopic versus laparotomic approach: a prospective longitudinal study 416
Steroid-free remission and closure of recto-vaginal fistula using adalimumab in a Crohn's disease patient naïve to anti-tumour necrosis factor alpha antibodies 416
Risk of lymphoma in patients with inflammatory bowel disease treated with azathioprine and 6-mercaptopurine: A meta-analysis 416
Interleukin-23R Arg381Gln Is Associated With Susceptibility to Crohn's Disease But Not With Phenotype in an Italian Population 415
A new oral delivery system for 5-ASA: Preliminary clinical findings for MMx 415
Accuracy of Small Intestine Contrast Ultrasonography, Compared to Computed Tomography Enteroclysis, in Characterizing Lesions in Patients with Crohn's Disease. 413
Frequency and pattern of endoscopic recurrence in Crohn's disease patients with ileocolonic resection using a laparoscopic versus laparotomic approach: A prospective longitudinal study 412
Colonic Phenotype of the Ileum in Crohn's Disease: A Prospective Study Before and after Ileocolonic Resection. 412
Cancer in Crohn's Disease patients treated with infliximab: a long-term multicenter matched pair study 411
Evidence of IL-17 producing innate lymphoid cells in peripheral blood from patients with enteropathic spondyloarthritis 410
A novel diagnostic tool for detecting functional patency of the small bowel: the given patency capsule 409
null 409
Liver abscess caused by foreign body ingestion 409
Wireless capsule endoscopy and small intestine contrast ultrasonography in recurrence of Crohn's disease 406
Small intestine contrast ultrasonography vs computed tomography enteroclysis for assessing ileal Crohn's disease. 406
Treatment with biologic therapies and the risk of cancer in patients with IBD. 406
Deletion of REXO1L1 locus in a patient with malabsorption syndrome, growth retardation, and dysmorphic features: A novel recognizable microdeletion syndrome? 406
Frequency, pattern, and risk factors of postoperative recurrence of Crohn's disease after resection different from ileo-colonic 404
Development of a numerical index quantitating small bowel damage as detected by ultrasonography in Crohn's disease 404
Efficacy and safety of infliximab and adalimumab in Crohn's disease: a single centre study 403
Hepatitis B virus infection and immunosuppressive therapy in patients with inflammatory bowel disease 402
Polymorphisms in MIR122, MIR196A2, and MIR124A genes are associated with clinical phenotypes in inflammatory bowel diseases 401
Non-invasive techniques for assessing postoperative recurrence in Crohn's disease 400
Effect of immunosuppressive therapy on patients with inflammatory bowel diseases and hepatitis B or C virus infection 399
Laparoscopic ileocolic resection for Crohn's disease associated with midgut malrotation 398
A Functional Role of Flip in Conferring Resistance of Crohn’s Disease Lamina Propria Lymphocytes to FAS-Mediated Apoptosis 398
European evidence based consensus on surgery for ulcerative colitis. 397
Wireless capsule endoscopy and proximal small bowel lesions in Crohn's disease. 396
Anti-TNF-alpha treatments and obstructive symptoms in Crohn's disease: a prospective study 396
Intestinal duplication in adulthood: A rare entity, difficult to diagnose 395
Infliximab in severe ulcerative colitis: short-term results of different infusion regimens and long-term follow-up 394
Infliximab three-dose induction regimen in severe corticosteroid-refractory ulcerative colitis: Early and late outcome and predictors of colectomy 394
Frequency, Pattern, and Risk Factors of Postoperative Recurrence of Crohn's Disease After Resection Different from Ileo-Colonic 393
Surgery for inflammatory bowel disease in the era of laparoscopy. 393
Is IBD an autoimmune disorder? 392
Imaging techniques for assessment of inflammatory bowel disease: Joint ECCO and ESGAR evidence-based consensus guidelines 391
Churg-Strauss syndrome development during asthma therapy with leukotriene receptor antagonists: just a coincidental association? 389
Wireless capsule endoscopy in Crohn’s disease: clinical relevance of upper GI lesions and feasibility 2 years after ileo-colonic resection. 388
Cytoskeletal proteins and resident flora 387
The Italian Society of Gastroenterology (SIGE) and the Italian Group for the study of Inflammatory Bowel Disease (IG-IBD) Clinical Practice Guidelines: The use of tumor necrosis factor-alpha antagonist therapy in Inflammatory Bowel Disease☆ 387
CARD15 mutation analysis in an Italian population: Leu1007fsinsC but neither Arg702Trp nor Gly908Arg mutations are associated with Crohn's disease 385
Ala197Thr is not associated with susceptibility to Crohn’s Disease or with phenotype in an Italian population. 385
Enhanced expression of the Fas pathway inhibitor, Flip, in the mucosa of patients with Crohn's disease 380
Single access laparoscopic ileocecal resection in complicated Crohn's disease. 380
I-123-interleukin-2 scintigraphy for in vivo assessment of intestinal mononuclear cell infiltration in Crohn's disease 379
Capsule endoscopy and proximal small bowel lesions in patients with Crohn’s disease. 379
Bowel Ultrasonography for Timely Diagnosis of Intestinal Acute Graft Versus Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation 379
Evolution of the Lesions Related to Crohn's Disease Recurrence As Assessed By Ultrasonography: A Prospective Longitudinal Study. 379
TRAF3IP2 gene is associated with cutaneous extraintestinal manifestations in Inflammatory Bowel Disease 376
Small bowel capsule endoscopy vs conventional techniques in patients with symptoms highly compatible with Crohn's disease. 373
Infliximab in the treatment of steroid resistant/dependant and fistulating Crohn's disease: An analysis of predictors of response in a italian multicentric open study in 573 patients 371
European evidence-based Consensus on the management of ulcerative colitis: Special situations 371
A Sonographic Lesion Index for Crohn's Disease Helps Monitor Changes in Transmural Bowel Damage During Therapy 371
Treatment of peri-anal fistula in Crohn's disease 370
Abilitazione Scientifica Nazionale - Professore I Fascia- Bando 2012 (DD n. 222/2012) 370
Comparison between techniques providing the luminal vs extraluminal surface in assessing Crohn’s disease recurrance: a prospective longitudinal study. 370
123I-interleukin-2 scintigraphy for in vivo assessment of intestinal mononuclear cell infiltration in Crohn's disease 369
Interleukin-21 enhances T-helper cell type I signaling and interferon-gamma production in Crohn's disease 369
Mongersen, an oral SMAD7 antisense oligonucleotide, and crohn's disease 369
Infliximab in the treatment of Crohn's disease: Predictors of response in an Italian multicentric open study 368
Advanced age is an independent risk factor for severe infections and mortality in patients given anti-tumor necrosis factor therapy for inflammatory bowel disease. 368
In Crohn's Disease Colonic Mucins Are Expressed in the Established Ileal Lesions at Surgery While heal Mucins Are Mainly Expressed in the Early Ileal Recurrence: A Prospective Longitudinal Study 368
European evidence-based consensus: Inflammatory bowel disease and malignancies 368
Long-term safety of Infliximab for the treatment of inflammatory bowel disease: does blocking TNFalpha reduce colitis-associated colorectal carcinogenesis? 360
Inter-observer agreement in endoscopic scoring systems: Preliminary report of an ongoing study from the Italian Group for Inflammatory Bowel Disease (IG-IBD) 360
Tc-99m HMPAO-labeled leukocyte scintigraphy with hybrid SPECT/CT detects perianal fistulas in Crohn disease 357
Interleukin-25 production is differently regulated by TNF-α and TGF-β1 in the human gut. 357
Diagnostic role of wireless capsule endoscopy in patients with symptoms highly compatible with Crohn's disease 355
Identificazione in vivo dell'infiltrato infiammatorio intestinale mediante metodiche scintigrafiche : applicazioni nella malattia di Crohn : 355
Effects of Anti-TNFA Treatments On Each Single Variable of the Crohn's Disease Activity Index (CDAI): A Prospective Longitudinal Study 353
Cancer risk in inflammatory bowel disease: a 6-year prospective multicenter nested case–control IG-IBD study 353
Phase I clinical trial of Smad7 knockdown using antisense oligonucleotide in patients with active Crohn's disease 352
null 352
Metastatic Crohn's disease of the forehead 348
Totale 40.322
Salva come PNG Salva come JPEG
Categoria #
all - tutte 114.393
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 114.393
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20208.612 0 0 0 0 0 1.573 1.281 1.327 1.291 1.199 931 1.010
2020/20218.868 948 951 931 1.041 866 1.002 1.263 875 221 259 386 125
2021/20222.218 88 228 97 173 176 154 106 92 290 192 115 507
2022/20232.262 266 166 64 275 190 519 215 133 200 27 135 72
2023/2024806 102 32 45 38 87 189 61 57 12 31 11 141
2024/20252.345 151 1.050 521 348 115 160 0 0 0 0 0 0
Totale 55.719